Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological ...

ClearML Joins VAST Cosmos as a Technology Partner to Deliver a Full-Stack AI Infrastructure Software Solution

ClearML integrates its AI Infrastructure Platform with the VAST AI Operating System to accelerate enterprise AI ...

Recursion Pharmaceuticals: Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

Fluency Named to Ad Age’s 2026 Best Places to Work for the Second Year in a Row

Company Behind Industry’s First Digital Advertising OS Ranked No. 1 for Technology and No. 6 Overall Among Companies ...

Op-Ed: Windows 12 — Speculation, pessimism, and when do users get a say?

Actual user requirements are usually buried in the hype for any OS. The theory of a low-cholesterol “Windows Lite”, aka ...

ImmunityBio: Disconnect Between Clinical Progress And Stock Performance

ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Techzine Europe

VAST Data leverages unique market position to develop full-stack AI infrastructure

VAST Data wants to be the Switzerland of the AI industry. Thanks to its relatively neutral market position, it can deliver full-stack data pipelines and infrastructure.